期刊文献+

ERK阻滞剂U0126对白血病细胞K562细胞周期的作用及机制 被引量:12

Effect of ERK pathway inhibitor U0126 on cell cycle of leukemia K562 cell lines
下载PDF
导出
摘要 目的研究细胞外信号调节激酶(extracellular signal-regulated kinase,ERK)阻滞剂U0126对K562细胞周期的作用及机制。方法以逆转录-聚合酶链反应(reverse transcription-polymerase chain reaction,RT-PCR)和Westernblot检测U0126处理K562细胞后ERK、Cyclin D2、Cyclin E、P27 mRNA和蛋白的表达;以流式细胞术(flow cytometry,FCM)检测细胞周期的变化。结果处理后K562细胞ERK、Cyclin D2、Cyclin E mRNA和蛋白表达降低;P27 mRNA和蛋白表达增高。G0/G1期细胞增多,S期细胞减少,与用药前相比差异均有统计学意义(P<0.05)。结论U0126可能通过ERK途径,影响细胞周期调控蛋白,最终抑制了K562细胞的增殖。 Objective To study the mechanism of extracellular signal-regulated kinase (ERK) pathway inhibitor U0126 on cell cycle of K562 cell lines. Methods The mRNA and protein expressions of ERK, Cyclin D2, Cyclin E in and P27 K562 cell lines after 10 μmol/L U0126 treatment for 12, 24 and 72 h were detected by RT-PCR and Western blot, respectively. The cell cycle was determined by flow cytometry. Results The mRNA and protein expressions of ERK, Cyclin D2 and Cyclin E in K562 cell lines after U0126 treatment were decreased, while those of P27 were increased. The percentage of cells in G0/G1 phase was increased and that in S phase was decreased. All data mentioned above showed significant difference between the K562 cell lines before and after U0126 treatment ( P 〈 0. 05 ). Conclusion U0126 possibly affects cell cycle regulating proteins by ERK pathway and eventually inhibits the proliferation of K562 cells.
作者 郭晓 潘崚
出处 《第三军医大学学报》 CAS CSCD 北大核心 2008年第5期393-395,共3页 Journal of Third Military Medical University
关键词 白血病 细胞周期 ERK K562细胞 U0126 leukemia cell cycle extracellular sigual-regulated kinase K562 cells U0126
  • 相关文献

参考文献11

  • 1王树森,管忠震,向燕群,汪波,林桐榆,姜文奇,张力,张惠忠,侯景辉.鼻咽癌组织中EGFR和p-ERK蛋白表达的检测及意义[J].中华肿瘤杂志,2006,28(1):28-31. 被引量:46
  • 2樊华,杜宏,张国君,王萍萍,王艳萍,卢香兰,李霞,金锋.VEGF和N-Ras及pERK1/2在急性髓系白血病骨髓中的表达及相关性研究[J].肿瘤防治杂志,2005,12(12):903-906. 被引量:4
  • 3Vicent S, Lopez-Picazo J M, Toledo G, et al. ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours [ J ]. BrJ Cancer, 2004, 90(5): 1047-1052.
  • 4郭晓,潘崚,侯兰芬,王友君,郭宏谋,杨琳,王志伟,孙宇,李栋梁.ERK和P38信号转导途径对慢性髓系白血病细胞周期的调控作用[J].中国实验血液学杂志,2007,15(2):242-247. 被引量:6
  • 5Vaque J P, Navascues J, Shiio Y, et aL Myc antagonizes Rastedia- ted growth arrest in leukemia cells through the inhibition of the RasERK-p21Cipl pathway[J]. J Biol Chem, 2005, 280(2): 1112 - 1122.
  • 6Pintus G, Tadolini B, Posadino A M, et al. PKC/Raf/MEK/ERK signaling pathway modulates nafive-LDL-induced E2F-1 gene expression and endothelial cell proliferation [ J ]. Cardiovasc Res, 2003, 59 ( 4 ) : 934 - 944.
  • 7Favata M F, Horiuchi K Y, Manos E J, et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase [ J ]. J Biol Chem, 1998, 273(29) : 18623 - 18632.
  • 8Hoshino R, Tanimura S, Watanabe K, et al. Blockade of the extracellular signal-regulated kinase pathway induces marked G1 cell cycle arrest and apoptosis in tumor cells in which the pathway is constitutively activated: up-regulation of P27(Kipl )[ J]. J Biol Chem, 2001, 276 (4) : 2686 - 2692.
  • 9Kortylewski M, Heinrich P C, Kauffmann M E, et al. Mitogen-activated protein kinases control P27/Kip1 expression and growth of human melanoma cells[J]. Biochem J, 2001,357(Pt 1 ) : 297 -303.
  • 10马洪德,蒋明德,曾维政.Erk信号传导通路与细胞周期调控[J].西南国防医药,2003,13(5):556-558. 被引量:14

二级参考文献58

  • 1Brabender J,Danenberg KD,Metzger R,et al.Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survival.Clin Cancer Res,2001,7:1850-1855.
  • 2Fromowitz FB,Viola MV,Chao S,et al.Ras p21 expression in the progression of breast cancer.Hum Pathol,1987,18:1268-1275.
  • 3Salomon DS,Brandt R,Ciardiello F,et al.Epidermal growth factorrelated peptides and their receptors in human malignancies.Crit Rev Oncol Hematol,1995,19:183-232.
  • 4Fujiii M,Yamashita T,Fshiguro R,et al.Significance of epidermal growth factor receptor and tumor associated tissue eosinophilia in the prognosis of patients with nasopharyngeal carcinoma.Auris Nasus Larynx,2002,29:175-181.
  • 5Putti TC,To KF,Hsu HC,et al.Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression:a multicentre immunohistochemical study in the AsiaPacific region.Histopathology,2002,41:144-151.
  • 6Yang HJ,Cho YJ,Kim HS,et al.Association of p53 and bcl-2expression with Epstein-Barr virus infection in the cancers of the head and neck.Head Neck,2001,23:629-636.
  • 7Ma B,Poon T,To KF,et al.Prognostic significance of tumor angiogenesis,KI67,p53 oncoprotein,epidermal growth factor receptor and HER2 receptor protein expressiosn in undifferentiated nasopharyngeal carcinoma:a prospective study.Head Neck,2003,25:864-872.
  • 8Sheen TS,Huang YZ,Chang YL,et al.Epstein-Barr virus-encoded latent membrane protein 1 co-expresses with epidermal growth factor receptor in nasopharyngeal carcinoma.Jpn J Cancer,1999,90:1285-1292.
  • 9Leong JL,Lob KS,Putti TC,et al.Epidermal growth factor receptor in undifferentiated carcinoma of the nasopharynx.Larygscope,2004,114:153-157.
  • 10Roychowdhury DF,Tseng A,Fu KK,et al.New prognostic factors in nasopharyngeal carcinoma.Cancer,1996,77:1419-1426.

共引文献69

同被引文献158

引证文献12

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部